100 related articles for article (PubMed ID: 2482820)
1. Expression of c-myb in embryonal carcinoma cells and embryonal stem cells.
Dyson PJ; Poirier F; Watson RJ
Differentiation; 1989 Oct; 42(1):24-7. PubMed ID: 2482820
[TBL] [Abstract][Full Text] [Related]
2. Oncogene expression in differentiating F9 mouse embryonal carcinoma cells.
Lockett TJ; Sleigh MJ
Exp Cell Res; 1987 Dec; 173(2):370-8. PubMed ID: 3691668
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional and post-transcriptional regulation of c-myc, c-myb, and p53 during proliferation and differentiation of murine erythroleukemia cells treated with DFMO and DMSO.
Klinken SP; Holmes KL; Morse HC; Thorgeirsson SS
Exp Cell Res; 1988 Oct; 178(2):185-98. PubMed ID: 2458948
[TBL] [Abstract][Full Text] [Related]
4. Loss of Oct-3/4 expression in embryonal carcinoma cells is associated with induction of cisplatin resistance.
Mueller T; Mueller LP; Luetzkendorf J; Voigt W; Simon H; Schmoll HJ
Tumour Biol; 2006; 27(2):71-83. PubMed ID: 16557044
[TBL] [Abstract][Full Text] [Related]
5. Studies of c-myb gene regulation in MRL-lpr/lpr mice. Identification of a 5' c-myb nuclear protein binding site and high levels of binding factors in nuclear extracts of lpr/lpr lymph node cells.
Mountz JD; Steinberg AD
J Immunol; 1989 Jan; 142(1):328-35. PubMed ID: 2642505
[TBL] [Abstract][Full Text] [Related]
6. Decrease in the c-myb gene transcript during differentiation of mouse teratocarcinoma stem cells.
Fukuda M; Ikuma S; Setoyama C; Shimada K
Biochem Int; 1987 Jul; 15(1):73-9. PubMed ID: 2840075
[TBL] [Abstract][Full Text] [Related]
7. Distal regulation of c-myb expression during IL-6-induced differentiation in murine myeloid progenitor M1 cells.
Zhang J; Han B; Li X; Bies J; Jiang P; Koller RP; Wolff L
Cell Death Dis; 2016 Sep; 7(9):e2364. PubMed ID: 27607579
[TBL] [Abstract][Full Text] [Related]
8. Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation.
Calao M; Sekyere EO; Cui HJ; Cheung BB; Thomas WD; Keating J; Chen JB; Raif A; Jankowski K; Davies NP; Bekkum MV; Chen B; Tan O; Ellis T; Norris MD; Haber M; Kim ES; Shohet JM; Trahair TN; Liu T; Wainwright BJ; Ding HF; Marshall GM
Oncogene; 2013 Aug; 32(31):3616-26. PubMed ID: 22907436
[TBL] [Abstract][Full Text] [Related]
9. Myb and NF-M: combinatorial activators of myeloid genes in heterologous cell types.
Ness SA; Kowenz-Leutz E; Casini T; Graf T; Leutz A
Genes Dev; 1993 May; 7(5):749-59. PubMed ID: 7684005
[TBL] [Abstract][Full Text] [Related]
10. Nuclear and cytoplasmic distribution of cellular myb protein in human haematopoietic cells evidenced by monoclonal antibody.
Bading H; Gerdes J; Schwarting R; Stein H; Moelling K
Oncogene; 1988 Sep; 3(3):257-65. PubMed ID: 3060791
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of jun and fos genes during differentiation of mouse P19 embryonal carcinoma cells.
de Groot RP; Schoorlemmer J; van Genesen ST; Kruijer W
Nucleic Acids Res; 1990 Jun; 18(11):3195-202. PubMed ID: 2113273
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the expression of the hematopoietic stem cell antigen CD34: role of c-myb.
Melotti P; Ku DH; Calabretta B
J Exp Med; 1994 Mar; 179(3):1023-8. PubMed ID: 7509358
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of the murine k-FGF gene in embryonic cell lines.
Ma YG; Rosfjord E; Huebert C; Wilder P; Tiesman J; Kelly D; Rizzino A
Dev Biol; 1992 Nov; 154(1):45-54. PubMed ID: 1426633
[TBL] [Abstract][Full Text] [Related]
14. Constitutive versus cell cycle regulation of c-myb mRNA expression correlates with developmental stages in murine B lymphoid tumors.
Catron KM; Purkerson JM; Isakson PC; Bender TP
J Immunol; 1992 Feb; 148(3):934-42. PubMed ID: 1730880
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of mouse erythroleukemia cells enhanced by alternatively spliced c-myb mRNA.
Weber BL; Westin EH; Clarke MF
Science; 1990 Sep; 249(4974):1291-3. PubMed ID: 2205003
[TBL] [Abstract][Full Text] [Related]
16. Microsatellite deletions in the c-myb transcriptional attenuator region associated with over-expression in colon tumour cell lines.
Thompson MA; Flegg R; Westin EH; Ramsay RG
Oncogene; 1997 Apr; 14(14):1715-23. PubMed ID: 9135073
[TBL] [Abstract][Full Text] [Related]
17. Pleiotropic derepression of developmentally regulated cellular and viral genes by c-myc protooncogene products in undifferentiated embryonal carcinoma cells.
Onclercq R; Lavenu A; Cremisi C
Nucleic Acids Res; 1989 Jan; 17(2):735-53. PubMed ID: 2536923
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid-induced differentiation of the developmentally pluripotent human germ cell tumor-derived cell line, NCCIT.
Damjanov I; Horvat B; Gibas Z
Lab Invest; 1993 Feb; 68(2):220-32. PubMed ID: 7680083
[TBL] [Abstract][Full Text] [Related]
19. c-Myb and Ets proteins synergize to overcome transcriptional repression by ZEB.
Postigo AA; Sheppard AM; Mucenski ML; Dean DC
EMBO J; 1997 Jul; 16(13):3924-34. PubMed ID: 9233802
[TBL] [Abstract][Full Text] [Related]
20. Human c-myb is expressed in cervical carcinomas and transactivates the HPV-16 promoter.
Nürnberg W; Artuc M; Nawrath M; Lovric J; Stüting S; Moelling K; Czarnetzki BM; Schadendorf D
Cancer Res; 1995 Oct; 55(19):4432-7. PubMed ID: 7671256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
